Cardiovascular health
Brings together the lipid profile, atherogenic risk, small-particle proportion and HDL efficiency: a combined view of cholesterol transport and removal.
An integrated picture of metabolic health,
in the context of age and sex.
A metabolic test based on nuclear magnetic resonance that combines multiple signals through analysis models into five metabolic dimensions.
For wellbeing clinics, nutritionists, preventive medicine and corporate health programmes.
Talk to the teamFrom a single blood sample, MetBalance uses nuclear magnetic resonance to obtain a broad profile of lipoproteins, glycoproteins and low-molecular-weight metabolites. It brings this information together into five metabolic dimensions and places it in the context of each person’s age and sex, giving a combined picture of their metabolic status beyond each individual result.
The report brings together overall metabolic health, estimated metabolic age and the results of the five dimensions analysed. Within each dimension, the signals are grouped by function and shown against their reference target.
Above 42% of people of the same age and sex.
4 years above the chronological age of 64.
Each dimension brings together signals that describe the same area of metabolism. Select one to see its interpretation and the results organised by function.
Brings together the lipid profile, atherogenic risk, small-particle proportion and HDL efficiency: a combined view of cholesterol transport and removal.
Glyc-A and Glyc-B capture glycoprotein signals associated with low-grade inflammatory processes.
Brings together glucose, lactate, ketone bodies and amino acids related to how the body produces and uses energy.
Groups amino acids related to protein synthesis and breakdown, muscle energy metabolism and adaptation to exercise.
Creatinine provides a signal related to kidney filtration; its interpretation should consider muscle mass, hydration, diet and exercise.
The score for each dimension combines how close its signals are to the applicable reference — including clinical ranges where they exist — and their context by age and sex. It does not express a diagnostic probability.
(*) Result outside the target shown in this example. Synthetic data; the position of each result is illustrative and requires professional interpretation.Each analytical value expresses the concentration of a metabolite in blood. MetBalance adds a second layer of information: it shows where that result sits compared with people of the same age and sex. This context does not change the analytical value or replace clinical criteria; it allows each signal to be interpreted more precisely within the overall metabolic profile. Below, two synthetic cases are compared: two men, aged 25 and 55, with the same triglyceride value — 146 mg/dL, just below the clinical threshold of 150 mg/dL. Although the analytical result is identical, its position within each reference distribution is different.
Above P75 for age and sex
In the highest 25% of the distribution. At 25, this value is higher than in most men of the same age, even though it does not reach the clinical threshold. It may prompt a review of habits such as diet and physical activity, and follow-up of its evolution together with the rest of the cardiovascular dimension.
Below P75 for age and sex
Outside the highest 25% of the distribution. At 55, the same value is common among men of the same age. Being common does not make it optimal: its reading is completed with the other signals in the cardiovascular dimension and clinical judgement.
Synthetic cases. The curves were estimated from a Spanish population-based cohort of adults and show how triglycerides are distributed in men of each age group; they do not reproduce the MetBalance calculation model. A metabolite’s position is not interpreted in isolation: MetBalance combines it with the other signals in the dimension and with the professional assessment.
MetBalance allows measurements taken under equivalent conditions to be compared, to observe how the metabolic profile changes during a nutrition, exercise or lifestyle programme. The combined view helps the professional explain progress and identify which dimensions still need attention.
Above 28% of people of the same age and sex.
7 years above the chronological age of 52.
Cardiovascular health
Inflammation
Energy metabolism
Muscle mass
Renal function
Conceptual example with synthetic data. The changes illustrate how longitudinal follow-up can be shown; they do not predict the response to an intervention or represent expected effects. The comparison requires measurements taken under equivalent conditions and professional interpretation.
Five settings where metabolic information adds value.
Comparable measurements throughout the programme.
A first measurement compares the metabolic profile with people of the same age and sex.
The professional defines the nutrition, exercise or lifestyle plan based on the five dimensions.
A measurement under equivalent conditions allows progress to be compared in a structured way.
Longitudinal comparison helps explain progress and identify which dimensions still need attention.
Built on research into metabolic health and longevity.
Multi-omics characterisation, including NMR metabolic profiling, of the person with the longest documented lifespan.
View publicationIt simultaneously analyses lipoproteins, glycoproteins and low-molecular-weight metabolites in blood using nuclear magnetic resonance.
Analysis models combine the signals into five metabolic dimensions and compare the profile with people of the same age and sex. This gives the overall position and the estimated metabolic age.
For wellbeing clinics, nutrition and preventive medicine professionals, and corporate health programmes that want to add metabolic information referenced to age and sex.
Yes. Measurements taken under comparable conditions make it possible to observe how the metabolic profile changes over time.
No. MetBalance provides complementary information on the metabolic profile and should be interpreted together with the professional’s judgement.
Tell us about your centre, the type of programme and how you want to use the information. We will propose the right workflow.
Request information